A Phase III Study of KN026 in Combination With HB1801 ± Carboplatin as Neoadjuvant Treatment for Early or Locally Advanced HER2-Positive Breast Cancer
Clinical trial NCT06747338 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06747338
- Sponsor
- Shanghai JMT-Bio Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-16
- Primary completion
- 2026-12-16
- Enrollment
- 520
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.